invIOs Publishes Clinical Data on APN401 Cell Therapy
invIOs published clinical data on its CBL-B-silenced autologous cell therapy APN401 in a peer-reviewed journal. The announcement characterizes the data as positive.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
EQS — News: invIOs publishes positive clinical data on CBL — B — silenced autologous cell therapy APN401 in peer — reviewed journal
EQS-News: invIOs GmbH / Key word(s): Scientific publication invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal 15.10.2026 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. ═══════════════════════════════════════════════